Source: Journal of Cardiac Failure. Unidade: FM
Subjects: PEPTÍDEO NATRIURÉTICO ATRIAL (ANÁLISE), SENSIBILIDADE E ESPECIFICIDADE, BIOLOGIA MELECULAR, RASTREAMENTO, FATORES DE RISCO, MIOCARDIOPATIA HIPERTRÓFICA (GENÉTICA;DIAGNÓSTICO)
ABNT
FERNANDES, Fabio et al. Plasma Pro-B-Type Natriuretic Peptide Testing as a Screening Method for Hypertrophic Cardiomyopathy. Journal of Cardiac Failure, v. 18, n. 7, p. 564-568, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.cardfail.2012.04.005,. Acesso em: 23 ago. 2024.APA
Fernandes, F., Arteaga-Fernandez, E., Antunes, M. de O., Buck, P., Marsiglia, J. D. C., Matsumoto, A., et al. (2012). Plasma Pro-B-Type Natriuretic Peptide Testing as a Screening Method for Hypertrophic Cardiomyopathy. Journal of Cardiac Failure, 18( 7), 564-568. doi:10.1016/j.cardfail.2012.04.005,NLM
Fernandes F, Arteaga-Fernandez E, Antunes M de O, Buck P, Marsiglia JDC, Matsumoto A, Nastari L, Krieger JE, Pereira AC, Mady C. Plasma Pro-B-Type Natriuretic Peptide Testing as a Screening Method for Hypertrophic Cardiomyopathy [Internet]. Journal of Cardiac Failure. 2012 ; 18( 7): 564-568.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.cardfail.2012.04.005,Vancouver
Fernandes F, Arteaga-Fernandez E, Antunes M de O, Buck P, Marsiglia JDC, Matsumoto A, Nastari L, Krieger JE, Pereira AC, Mady C. Plasma Pro-B-Type Natriuretic Peptide Testing as a Screening Method for Hypertrophic Cardiomyopathy [Internet]. Journal of Cardiac Failure. 2012 ; 18( 7): 564-568.[citado 2024 ago. 23 ] Available from: https://doi.org/10.1016/j.cardfail.2012.04.005,